Literature DB >> 8048535

Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic rats.

Z Ma1, J B Meddings, S S Lee.   

Abstract

To elucidate the basic membrane mechanisms underlying cirrhotic cardiomyopathy, cardiac sarcolemmal plasma membrane physical properties, chemical composition, beta-adrenoceptor density, binding affinity, and isoproterenol-stimulated adenosine 3',5'-cyclic monophosphate (cAMP) production were studied. Cirrhosis was induced by chronic bile duct ligation, while controls underwent a sham operation. The cardiac plasma membrane of cirrhotic rats was found to be more rigid than controls, primarily due to an increased cholesterol-to-phospholipid ratio. In cirrhotic animals, beta-adrenergic dysfunction was evident with a 21% decrease in beta-adrenoceptor density but no alteration in binding affinity. Despite the modest decrease in receptor number, beta-adrenoceptor-stimulated cAMP production was decreased by 37% in cirrhotic rats. When the membrane physical properties of the cirrhotic rats were restored to normal, by incubation with the fluidizing agent 2-(2-methoxy-ethoxy)ethyl 8-(cis-2-n-octylcyclopropyl)octanoate (A2C), isoproterenol-stimulated cAMP production also increased to levels indistinguishable from control animals. Restoration of membrane physical properties had no effect on either beta-adrenoceptor density or binding affinity. These results suggest that the increased rigidity of cardiomyocyte plasma membranes seen with cirrhosis is associated with decreased beta-adrenoceptor function. Moreover, restoring normal physical properties may result in restoration of beta-adrenoceptor-mediated contractile function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8048535     DOI: 10.1152/ajpgi.1994.267.1.G87

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

Review 1.  Cardiac evaluation of liver transplant candidates.

Authors:  Mercedes Susan Mandell; Joann Lindenfeld; Mei-Yung Tsou; Michael Zimmerman
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

Review 2.  Role of cardiovascular intervention as a bridge to liver transplantation.

Authors:  Zankhana Raval; Matthew E Harinstein; James D Flaherty
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  Cirrhotic cardiomyopathy: a cardiologist's perspective.

Authors:  Natig Gassanov; Evren Caglayan; Nasser Semmo; Gero Massenkeil; Fikret Er
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 4.  Recent advances in cirrhotic cardiomyopathy.

Authors:  Dimitrios S Karagiannakis; George Papatheodoridis; Jiannis Vlachogiannakos
Journal:  Dig Dis Sci       Date:  2014-11-18       Impact factor: 3.199

5.  Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia.

Authors:  Dimitrios S Karagiannakis; Jiannis Vlachogiannakos; Georgios Anastasiadis; Irini Vafiadis-Zouboulis; Spiros D Ladas
Journal:  Dig Dis Sci       Date:  2013-08-02       Impact factor: 3.199

6.  Changes in plasma membrane fluidity lower the sensitivity of S. cerevisiae to killer toxin K1.

Authors:  H Flegelová; R Chaloupka; D Novotná; J Malác; D Gásková; K Sigler; B Janderová
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

7.  Protective role of cardiac-specific overexpression of caveolin-3 in cirrhotic cardiomyopathy.

Authors:  So Yeon Kim; Kang Ho Kim; Jan M Schilling; Joseph Leem; Mehul Dhanani; Brian P Head; David M Roth; Alice E Zemljic-Harpf; Hemal H Patel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-21       Impact factor: 4.052

Review 8.  Cardiac and vascular changes in cirrhosis: pathogenic mechanisms.

Authors:  HongQun Liu; Seyed Ali Gaskari; Samuel S Lee
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

9.  Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations.

Authors:  Lisa B VanWagner; Matthew E Harinstein; James R Runo; Christopher Darling; Marina Serper; Shelley Hall; Jon A Kobashigawa; Laura L Hammel
Journal:  Am J Transplant       Date:  2017-11-18       Impact factor: 8.086

10.  Cirrhotic cardiomyopathy: review of pathophysiology and treatment.

Authors:  Maneerat Chayanupatkul; Suthat Liangpunsakul
Journal:  Hepatol Int       Date:  2014-07       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.